FDA approves generic drugs for type 2 diabetes by Aurobindo

02/17/2013 | Pharmaceutical Business Review Online

Aurobindo Pharma received FDA approval to market its pioglitazone tablets in three strengths and its pioglitazone hydrochloride and metformin hydrochloride tablets in two doses. Both drugs are indicated as added therapy, alongside exercise and diet, to assist with glycemic control in patients with type 2 diabetes.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ